OGN

NEUTRALM&A

Organon & Co.

2026-07-06

Price

$13.56

+0.07%

This is the 2026-07-06 snapshot — the signals and analysis for OGN as of this single trading day.

View full OGN research hub →

Score12.5Top Tier

Signals5/8 DNA1/13 Act · 0/4 Risk

SentimentNEUTRALScore: 7

Volume0.8xvs 20d avg

Analysis

Organon's (OGN) price action is entirely dictated by its pending $14.00 per share all-cash acquisition by Sun Pharmaceutical Industries. The presence of low-volatility technical signals like QUIET_STORM and STEADY_CLIMB confirms High-Conviction Price Discovery, mirroring institutional merger arbitrage accumulation as the stock trades at a slight discount ($13.56) to the deal price. Furthermore, the current RISK_ON macro regime, characterized by exceptionally tight credit spreads (0.75% OAS), provides extreme conviction that financing and broader market conditions will smoothly support the acquisition's closure.

Fired Signals

ALPHA MALEQUIET STORMSTEADY CLIMBGOLDEN CROSSPERFECT STACKSELLER FATIGUE

Key Takeaways

Actionable Thesis: OGN is a pure merger arbitrage play offering a steady, low-risk yield up to the $14.00 takeout price, supported by highly accommodative credit markets.
Key Risk: Regulatory pushback or shareholder lawsuits (such as ongoing fiduciary investigations by law firms) could delay or jeopardize the deal timeline.
What to Watch: Monitor the $13.34 support level, as a structural break below this would signal institutional doubts regarding deal completion.

← Back to 2026-07-06 View Full OGN History →Yahoo Finance &nearr;